Format

Send to

Choose Destination
Medicine (Baltimore). 2018 Mar;97(12):e0167. doi: 10.1097/MD.0000000000010167.

Statin in the treatment of patients with myocardial infarction: A meta-analysis.

Author information

1
Department of Cardiac Function, Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Abstract

The purpose of this meta-analysis is to investigate whether statin is a key therapy for myocardial infarction (MI) by comparing all randomized controlled trials that appraised the effects of statin on risk of MI.Pubmed, Embase, and Medline databases (up to December 2016) were used to search all related articles. Using the data from 18 available publications, we examined the efficacy in treating or reducing the risk of MI by using random-effects models of odds ratio (OR) comparing the highest with the lowest category.Statins have demonstrated efficacy in treating or reducing the risk of MI (OR = 0.73, 95% confidence interval = 0.58-0.93, P = .010).This meta-analysis suggests that statin have light efficacy in treating or reducing the risk of MI patients.

PMID:
29561426
PMCID:
PMC5895306
DOI:
10.1097/MD.0000000000010167
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center